ArticleBiomedical engineering online2025
Odontogenic/osteogenic differentiation of dental pulp stem cells on a Biodentine-coated polymer nanofibers.
Article in Biomedical engineering online, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Modifications of Biodentine and Their Influence on Endodontic Properties: A Scoping Review.International journal of dentistry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTissue engineering has become increasingly applied for tissue repair purposes. Scaffolds, one of the main components of tissue engineering, provide a supportive framework for cell culture and growth. The objective of the present study was to investigate the odontogenic/osteogenic differentiation of dental pulp stem cells, cultured on a polycaprolactone (PCL)-based nanofibrous scaffold, coated with Biodentine. This study evaluated the use of Biodentine as a coating on nanofiber scaffolds and investigated the biological effects of this material on the differentiation of dental pulp stem cells, which hold promising applications in dental and bone tissue engineering.
methodsThis study is a basic research investigation. Initially, PCL nanofibrous scaffolds were produced through electrospinning, followed by a post-fabrication surface modification step. The morphology and properties of the scaffolds were examined using scanning electron microscopy (SEM). In the surface treatment step, two different concentrations of Biodentine (0.05% and 0.01%) were applied on the mats. The biocompatibility of the scaffolds was assessed using an MTT assay on days 1, 3, and 5. Additionally, the odontogenic/osteogenic differentiation potency of fabricated scaffolds was evaluated by alkaline phosphatase (ALP) activity and deposited calcium of the cells on days 7, 14, and 21.
resultsSEM analysis revealed that Biodentine coating increased surface roughness, particularly at the 0.05% concentration, where excessive particle aggregation was observed. In contrast, the control PCL scaffold exhibited a well-organized fibrous structure with a smooth surface, whereas the 0.01% Biodentine-coated scaffold displayed a moderately roughened surface with uniformly distributed mineralized deposits. Cell viability was higher in the 0.01% Biodentine group, while the 0.05% concentration showed reduced proliferation. ALP activity peaked on day 14, and the highest level of calcium deposition was observed in the 0.01% Biodentine group on day 21, indicating enhanced biomineralization.
conclusionBiodentine/PCL scaffolds demonstrated notable and suitable physical and chemical properties. Furthermore, they enhanced odontogenic/osteogenic differentiation and mineralization compared to the control group. These findings support the potential of fabricated scaffolds for odontogenic/osteogenic differentiation applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.